{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:01:48Z","timestamp":1791824508140,"version":"4.3.4"},"reference-count":202,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.3233\/jad-160517","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T11:28:58Z","timestamp":1467977338000},"page":"859-878","source":"Crossref","is-referenced-by-count":84,"title":["Anti-Viral Properties of Amyloid-\u03b2 Peptides"],"prefix":"10.1177","volume":"54","author":[{"given":"Karine","family":"Bourgade","sequence":"first","affiliation":[{"name":"Research Center on Aging, Graduate Program in Immunology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Dupuis","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Graduate Program in Immunology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Frost","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e0s","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[{"name":"Department of Medicine, Research Center on Aging, Graduate Program in Immunology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160517_ref1","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allgemeine Zeitschrift f\u00fcr Psychiatrie und Psychisch-Gerichtliche Medizine"},{"key":"10.3233\/JAD-160517_ref2","doi-asserted-by":"crossref","first-page":"254954","DOI":"10.1155\/2013\/254954","article-title":"Genetics of Alzheimer\u2019s disease","volume":"2013","author":"Ridge","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.3233\/JAD-160517_ref3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1017\/S0317167100013408","article-title":"Amyloid and Alzheimer\u2019s disease: Inside and out","volume":"39","author":"Tam","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-160517_ref4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","article-title":"Alzheimer disease","volume":"56","author":"Castellani","year":"2010","journal-title":"Dis Mon"},{"key":"10.3233\/JAD-160517_ref5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2013","journal-title":"Lancet"},{"key":"10.3233\/JAD-160517_ref7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YCO.0b013e32835f414b","article-title":"Agitation and aggression in people with Alzheimer\u2019s disease","volume":"26","author":"Ballard","year":"2013","journal-title":"Curr Opin Psychiatry"},{"key":"10.3233\/JAD-160517_ref8","doi-asserted-by":"crossref","first-page":"927804","DOI":"10.1155\/2014\/927804","article-title":"Behavioral and psychological symptoms in Alzheimer\u2019s disease","volume":"2014","author":"Li","year":"2014","journal-title":"BioMed Res Intern"},{"key":"10.3233\/JAD-160517_ref12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbagen.2009.07.016","article-title":"The unsolved relationship of brain aging and late-onset Alzheimer disease","volume":"10","author":"Kern","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160517_ref13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-160517_ref14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/1567205013666160222112444","article-title":"Peripheral immune signatures in Alzheimer disease","volume":"13","author":"Goldeck","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-160517_ref15","first-page":"23","article-title":"Elusive Alzheimer\u2019s disease: Can immune signatures help our understanding of this challenging disease? Part 1: Clinical and historical background","volume":"15","author":"Fulop","year":"2013","journal-title":"Discov Med"},{"key":"10.3233\/JAD-160517_ref16","first-page":"33","article-title":"Elusive Alzheimer\u2019s disease: Can immune signatures help our understanding of this challenging disease? Part 2: New immune paradigm","volume":"15","author":"Fulop","year":"2013","journal-title":"Discov Med"},{"key":"10.3233\/JAD-160517_ref17","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-160517_ref18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-160517_ref19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer\u2019s disease: An appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-160517_ref20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"Alzheimer\u2019s disease facts and figures Alzheimer\u2019s Association Report 2013","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimer Dement"},{"key":"10.3233\/JAD-160517_ref21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/alzrt213","article-title":"Dominantly inherited Alzheimer network: Facilitating research and clinical trials","volume":"5","author":"Moulder","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160517_ref22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.npp.1300668","article-title":"Ibuprofen suppresses interleukin-1\u03b2 induction of pro-amyloidogenic \u03b11-antichymotrypsin to ameliorate \u03b2-amyloid (A\u03b2) pathology in Alzheimer\u2019s models","volume":"30","author":"Morihara","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-160517_ref23","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160517_ref24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00415-011-6145-3","article-title":"Alzheimer\u2019s disease","volume":"259","author":"Galimberti","year":"2012","journal-title":"J Neurol"},{"key":"10.3233\/JAD-160517_ref25","doi-asserted-by":"crossref","unstructured":"Scheltens P , Blennow K , Breteler MM , de Strooper B , Frisoni GB , Salloway S , Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet. doi: 10.1016\/S0140-6736(15)01124-1","DOI":"10.1016\/S0140-6736(15)01124-1"},{"key":"10.3233\/JAD-160517_ref26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5114\/fn.2013.37702","article-title":"What causes Alzheimer\u2019s disease?","volume":"51","author":"Armstrong","year":"2013","journal-title":"Folia Neuropathol"},{"issue":"Suppl 4","key":"10.3233\/JAD-160517_ref27","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.3233\/JAD-141248","article-title":"Contributions of a risk assessment approach to the prevention of Alzheimer\u2019s disease and dementia","volume":"42","author":"Anstey","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref28","doi-asserted-by":"crossref","unstructured":"Chin-Chan M , Navarro-Yepes J , Quintanilla-Vega B (2015) Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 9, Article 124.","DOI":"10.3389\/fncel.2015.00124"},{"key":"10.3233\/JAD-160517_ref29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrneurol.2014.15","article-title":"Network dysfunction after traumatic brain injury","volume":"10","author":"Sharp","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-160517_ref30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.nut.2013.01.024","article-title":"Nutritional approaches in the risk reduction and management of Alzheimer\u2019s disease","volume":"29","author":"Mi","year":"2013","journal-title":"Nutrition"},{"issue":"Suppl 4","key":"10.3233\/JAD-160517_ref31","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.3233\/JAD-141539","article-title":"Preventive benefits of natural nutrition and lifestyle counseling against Alzheimer\u2019s disease onset","volume":"42","author":"Polidori","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1479-8301.2009.00294.x","article-title":"Vascular pathology in Alzheimer\u2019s disease","volume":"10","author":"Miyakawa","year":"2010","journal-title":"Psychogeriatrics"},{"key":"10.3233\/JAD-160517_ref33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.neurobiolaging.2012.09.011","article-title":"The capillary dysfunction hypothesis of Alzheimer\u2019s disease","volume":"34","author":"\u00d8stergaard","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160517_ref34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160517_ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-4580(93)90015-4","article-title":"The role of cortical connectivity in Alzheimer\u2019s disease pathogenesis: A review and model system","volume":"14","author":"De Lacoste","year":"1993","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160517_ref36","first-page":"212","article-title":"Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer\u2019s disease","volume":"7","author":"Nochlin","year":"1993","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-160517_ref37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","article-title":"Genetic insights in Alzheimer\u2019s disease","volume":"12","author":"Bettens","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160517_ref38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s13311-014-0295-9","article-title":"Genetics of Alzheimer\u2019s disease","volume":"11","author":"Guerreiro","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-160517_ref39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","article-title":"Alzheimer\u2019s disease genetics: From the bench to the clinic","volume":"83","author":"Karch","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-160517_ref40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.tins.2015.08.008","article-title":"Innate immunity fights Alzheimer\u2019s disease","volume":"38","author":"Guillot-Sestier","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-160517_ref41","doi-asserted-by":"crossref","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: The challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-160517_ref42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","article-title":"Implication of the immune system in Alzheimer\u2019s disease: Evidence from genome-wide pathway analysis","volume":"20","author":"Lambert","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-12-394625-6.00007-6","article-title":"Mitochondrial dysfunction: Cause and consequence of Alzheimer\u2019s disease","volume":"127","author":"Friedland-Leuner","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-160517_ref44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2990.2008.01005.x","article-title":"Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases","volume":"35","author":"Stolp","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-160517_ref45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jalz.2012.07.005","article-title":"Intracerebral propagation of Alzheimer\u2019s disease: Strengthening evidence of a herpes simplex virus etiology","volume":"9","author":"Ball","year":"2013","journal-title":"Alzheimer Dement"},{"key":"10.3233\/JAD-160517_ref46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neurobiolaging.2003.12.021","article-title":"Infiltration of the brain by pathogens causes Alzheimer\u2019s disease","volume":"25","author":"Itzhaki","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160517_ref47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/epirev\/mxs007","article-title":"Can infections cause Alzheimer\u2019s disease?","volume":"35","author":"Mawanda","year":"2013","journal-title":"Epidemiol Rev"},{"key":"10.3233\/JAD-160517_ref48","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399411002006","article-title":"Emerging roles of pathogens in Alzheimer disease","volume":"13","author":"Miklossy","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"10.3233\/JAD-160517_ref49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-142853","article-title":"Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer\u2019s disease","volume":"48","author":"Harris","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"De Chiara","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160517_ref51","first-page":"515248","article-title":"Alzheimer\u2019s disease: Exploring the role of inflammation and implications for treatment","volume":"2015","author":"McCaulley","year":"2015","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref52","doi-asserted-by":"crossref","first-page":"756357","DOI":"10.1100\/2012\/756357","article-title":"A review: Inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JAD-160517_ref53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160517_ref54","doi-asserted-by":"crossref","first-page":"549e55","DOI":"10.1016\/j.micinf.2015.04.004","article-title":"Infection, systemic inflammation, and Alzheimer\u2019s disease","volume":"17","author":"Lim","year":"2015","journal-title":"Microbes Infect"},{"key":"10.3233\/JAD-160517_ref55","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/502S84a","article-title":"Mapping the brain\u2019s decline","volume":"502","author":"Williams","year":"2013","journal-title":"Nature"},{"key":"10.3233\/JAD-160517_ref56","first-page":"a006296","article-title":"The genetics of Alzheimer disease","volume":"2","author":"Tanzi","year":"2012","journal-title":"Cold Spr Harb Perspect Med"},{"key":"10.3233\/JAD-160517_ref57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.3233\/JAD-160517_ref58","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1073\/pnas.85.19.7341","article-title":"\u03b2-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues","volume":"85","author":"Selkoe","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160517_ref59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.exger.2012.07.009","article-title":"Expression and function of APP and its metabolites outside the central nervous system","volume":"48","author":"Puig","year":"2013","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-160517_ref60","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse formation and function is modulated by the amyloid precursor protein","volume":"26","author":"Priller","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160517_ref61","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.108712","article-title":"Amyloid precursor protein and neural development","volume":"141","author":"Nicolas","year":"2014","journal-title":"Development"},{"key":"10.3233\/JAD-160517_ref62","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12675","article-title":"Insights into the physiological function of the \u03b2-amyloid precursor protein: Beyond Alzheimer\u2019s disease","volume":"129","author":"Dawkins","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160517_ref63","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.devcel.2015.01.022","article-title":"Cellular functions of the amyloid precursor protein from development to dementia","volume":"32","author":"van der Kant","year":"2015","journal-title":"Dev Cell"},{"key":"10.3233\/JAD-160517_ref64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0896-6273(90)90169-G","article-title":"The Alzheimer amyloid precursor-related transcript lacking the \u03b2\/A4 sequence is specifically increased in Alzheimer\u2019s disease brain","volume":"5","author":"Neve","year":"1990","journal-title":"Neuron"},{"key":"10.3233\/JAD-160517_ref65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-160517_ref66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/CIA.S51571","article-title":"The genetics of Alzheimer\u2019s disease","volume":"9","author":"Bagyinszky","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-160517_ref67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-160517_ref68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-132225","article-title":"Modifiable lifestyle factors in dementia: A systematic review of longitudinal observational cohort studies","volume":"42","author":"Di Marco","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0891988714554707","article-title":"Association between polymorphisms of the insulin-degrading enzyme gene and late-onset Alzheimer disease","volume":"28","author":"Wang","year":"2015","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-160517_ref70","first-page":"489428","article-title":"Apolipoprotein E: Essential catalyst of the Alzheimer amyloid cascade","volume":"2012","author":"Potter","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12415","article-title":"Integrative genomics identifies APOE \u025b4 effectors in Alzheimer\u2019s disease","volume":"500","author":"Rhinn","year":"2013","journal-title":"Nature"},{"key":"10.3233\/JAD-160517_ref72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-0031-1299784","article-title":"Genetics of dementia","volume":"31","author":"Paulson","year":"2011","journal-title":"Semin Neurol"},{"key":"10.3233\/JAD-160517_ref73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-012-0996-2","article-title":"The genetics and neuropathology of Alzheimer\u2019s disease","volume":"124","author":"Schellenberg","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160517_ref74","doi-asserted-by":"crossref","first-page":"576383","DOI":"10.1155\/2013\/576383","article-title":"The innate immune system in Alzheimer\u2019s disease","volume":"2013","author":"Boutajangout","year":"2013","journal-title":"Int J Cell Biol"},{"key":"10.3233\/JAD-160517_ref75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/cge.12108","article-title":"TREM2: A new risk factor for Alzheimer\u2019s disease","volume":"83","author":"Singaraja","year":"2013","journal-title":"Clin Genet"},{"key":"10.3233\/JAD-160517_ref76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2741\/E605","article-title":"Genetics of familial and sporadic Alzheimer\u2019s disease","volume":"5","author":"Piaceri","year":"2013","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.3233\/JAD-160517_ref77","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0021-9258(17)42286-1","article-title":"Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons","volume":"269","author":"Sandbrink","year":"1994","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160517_ref78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(97)00045-4","article-title":"Cell specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes","volume":"47","author":"Rohan de Silva","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-160517_ref79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10408360903335821","article-title":"The structure and function of Alzheimer\u2019s gamma secretase enzyme complex","volume":"46","author":"Krishnaswamy","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.3233\/JAD-160517_ref80","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.01323","article-title":"The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor","volume":"117","author":"von Rotz","year":"2004","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-160517_ref81","doi-asserted-by":"crossref","first-page":"23515","DOI":"10.1074\/jbc.R115.677211","article-title":"Amyloid precursor protein (APP) metabolites APP intracellular fragment (AICD), A\u03b242, and Tau in nuclear roles","volume":"290","author":"Multhaup","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160517_ref82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn785","article-title":"\u03b3-Secretase, Notch, A\u03b2 and Alzheimer\u2019s disease: Where do the presenilins fit in?","volume":"3","author":"Sisodia","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-160517_ref83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-1-19","article-title":"Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system","volume":"1","author":"Zheng","year":"2012","journal-title":"Transl Neurodegener"},{"key":"10.3233\/JAD-160517_ref84","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the \u03b2 amyloid protein is critical for the seeding of ayloid formation: Implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160517_ref85","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: An emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160517_ref86","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: The keypeptide in the pathogenesis of Alzheimer\u2019s disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-160517_ref87","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1111\/j.1742-4658.2011.08228.x","article-title":"Membrane and surface interactions of Alzheimer\u2019s A\u03b2 peptide - insights into the mechanism of cytotoxicity","volume":"278","author":"Williams","year":"2011","journal-title":"FEBS J"},{"issue":"Suppl 1","key":"10.3233\/JAD-160517_ref88","first-page":"359","article-title":"Long night\u2019s journey into the day: Amyloid-\u03b2 imaging in Alzheimer\u2019s disease","volume":"33","author":"Villemagne","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 1","key":"10.3233\/JAD-160517_ref89","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3233\/JAD-132054","article-title":"Intracellular and extracellular roles for tau in neurodegenerative disease","volume":"40","author":"Hanger","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref90","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pathol-020712-163927","article-title":"Emerging concepts in Alzheimer\u2019s disease","volume":"10","author":"Vinters","year":"2015","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.3233\/JAD-160517_ref91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-160517_ref92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-540-34449-0_5","article-title":"Misregulation of tau alternative splicing in neurodegeneration and dementia","volume":"44","author":"Andreadis","year":"2006","journal-title":"Prog Mol Subcell Biol"},{"key":"10.3233\/JAD-160517_ref93","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: Imlications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-160517_ref94","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/iub.1384","article-title":"Microtubule-associated proteins as direct crosslinkers of actin filaments and microtubules","volume":"67","author":"Mohan","year":"2015","journal-title":"IUBMB Life"},{"key":"10.3233\/JAD-160517_ref95","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein \u03c4 (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160517_ref96","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/oxfordjournals.jbchem.a135662","article-title":"Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer\u2019s disease","volume":"99","author":"Ihara","year":"1986","journal-title":"J Biochem (Tokyo)"},{"key":"10.3233\/JAD-160517_ref97","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (\u03c4) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160517_ref98","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","article-title":"Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease","volume":"268","author":"K\u00f6pke","year":"1993","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160517_ref99","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12264-013-1415-y","article-title":"Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer\u2019s disease","volume":"30","author":"Wang","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.3233\/JAD-160517_ref100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0021-9258(18)48529-8","article-title":"Assembly and aggregation properties of synthetic Alzheimer\u2019s A4\/beta amyloid peptide analogs","volume":"267","author":"Burdick","year":"1992","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160517_ref101","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein. (A\u03b2) in Alzheimer\u2019s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A\u03b240 or A\u03b242(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160517_ref102","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1021\/bi500373k","article-title":"Interaction of Alzheimer\u2019s \u03b2amyloid peptides with cholesterol: Mechanistic insights into amyloid pore formation","volume":"53","author":"Di","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160517_ref103","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.bbamem.2007.04.021","article-title":"Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm","volume":"1768","author":"Lal","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160517_ref104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2007.09.023","article-title":"The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer\u2019s disease","volume":"427","author":"Giedraitis","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160517_ref105","first-page":"S111","article-title":"The role of amyloid-beta in the regulation of memory","volume":"33","author":"Morley","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref106","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuroeptides","volume":"250","author":"Yankner","year":"1990","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref107","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"Beta-amyloid monomers are neuroprotective","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160517_ref108","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/REVNEURO.2010.21.2.83","article-title":"The monomer state of beta-amyloid: Where the Alzheimer\u2019s disease protein meets physiology","volume":"21","author":"Giuffrida","year":"2010","journal-title":"Rev Neurosci"},{"key":"10.3233\/JAD-160517_ref109","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.3233\/JAD-2012-129033","article-title":"Amyloid-\u03b2 peptide: Dr. Jekyll or Mr. Hyde?","volume":"33","author":"Puzzo","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref110","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.3233\/JAD-160517_ref111","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref112","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160517_ref113","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: Time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160517_ref114","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2885","article-title":"Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is \u2018too big to fail\u2019","volume":"224","author":"Castellani","year":"2011","journal-title":"J Pathol"},{"key":"10.3233\/JAD-160517_ref115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: The role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-160517_ref116","first-page":"1005","article-title":"Inflammation in Alzheimer disease: Driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"key":"10.3233\/JAD-160517_ref117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/alzrt271","article-title":"Cerebral inflammation is an underlying mechanism of early death in Alzheimer\u2019s disease: A 13-year cause-specific multivariate mortality study","volume":"6","author":"N\u00e4gga","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160517_ref118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","article-title":"Deciphering the mechanism underlying late-onset Alzheimer disease","volume":"9","author":"Krstic","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 1","key":"10.3233\/JAD-160517_ref119","first-page":"S123","article-title":"Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration.S123-S","volume":"33","author":"Wang","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref120","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref121","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2014.00176","article-title":"Alzheimer\u2019s disease: Relevant molecular and physiopathological events affecting amyloid-\u03b2 brain balance and the putative role of PPARs","volume":"6","author":"Zolezzi","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-160517_ref122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int J Neurosci"},{"key":"10.3233\/JAD-160517_ref123","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbi.2015.07.021","article-title":"Microglia in Alzheimer\u2019s disease: A multifaceted relationship","volume":"55","author":"ElAli","year":"2016","journal-title":"Brain Behavior Immun"},{"key":"10.3233\/JAD-160517_ref124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","article-title":"Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer\u2019s disease","volume":"17","author":"Larbi","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 1","key":"10.3233\/JAD-160517_ref125","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-160517_ref126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10522-015-9615-7","article-title":"From inflamm-aging to immune-paralysis: A slippery slope during aging for immune-adaptation","volume":"17","author":"Fulop","year":"2016","journal-title":"Biogerontology"},{"key":"10.3233\/JAD-160517_ref127","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000381134","article-title":"Frailty, inflammation and immunosenescence","volume":"41","author":"Fulop","year":"2015","journal-title":"Interdiscip Top Gerontol Geriatr"},{"key":"10.3233\/JAD-160517_ref128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coi.2014.05.005","article-title":"Human CNS immune senescence and neurodegeneration","volume":"29C","author":"Streit","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.3233\/JAD-160517_ref129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J","article-title":"Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices","volume":"33","author":"Stence","year":"2001","journal-title":"Glia"},{"key":"10.3233\/JAD-160517_ref130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnagi.2013.00026","article-title":"Brain injury, neuroinflammation and Alzheimer\u2019s disease","volume":"5","author":"Breunig","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-160517_ref131","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160517_ref132","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00281-015-0518-0","article-title":"\u03b2-amyloid, microglia, and the inflammasome in Alzheimer\u2019s disease","volume":"37","author":"Gold","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.3233\/JAD-160517_ref133","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10571-014-0101-6","article-title":"Microglial A\u03b2 receptors in Alzheimer\u2019s disease","volume":"35","author":"Yu","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-160517_ref134","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-160517_ref135","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.3233\/JAD-160517_ref136","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s Disease","volume":"33","author":"Lee","year":"2010","journal-title":"Arch Pharm Res"},{"key":"10.3233\/JAD-160517_ref137","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000356529","article-title":"Innate imune system and inflammation in Alzheimer\u2019s disease: From pathogenesis to treatment","volume":"21","author":"Serpente","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.3233\/JAD-160517_ref138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-143054","article-title":"NK cells are activated in amnestic mild cognitive impairment but not in mild Alzheimer\u2019s disease patients","volume":"46","author":"Le Page","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref139","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2014.00171","article-title":"Systemic inflammation, blood-brain barrier vulnerability and cognitive\/non-cognitive symptoms in Alzheimer disease: Relevance to pathogenesis and therapy","volume":"6","author":"Takeda","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-160517_ref140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2013.01.002","article-title":"Systemic immune system alterations in early stages of Alzheimer\u2019s disease","volume":"256","author":"Zhang","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-160517_ref141","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-160517_ref142","first-page":"173","article-title":"Emerging concepts of how \u00df-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an \u2018Alzheimer brain\u2019","volume":"1","author":"Dal Pra","year":"2008","journal-title":"Mol Med Rep"},{"key":"10.3233\/JAD-160517_ref143","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-8-38","article-title":"Blood-brain-barriers in aging and in Alzheimer\u2019s disease","volume":"8","author":"Marques","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-160517_ref144","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.3233\/JAD-160517_ref145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3233\/JAD-160152","article-title":"Microbes and Alzheimer\u2019s disease","volume":"51","author":"Itzhaki","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160517_ref146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12979-014-0026-4","article-title":"Alzheimer\u2019s disease and infections, where we stand and where we go","volume":"11","author":"Monastero","year":"2014","journal-title":"Immun Ageing"},{"key":"10.3233\/JAD-160517_ref147","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neurobiolaging.2003.12.022","article-title":"Challenges and directions for the pathogen hypothesis of Alzheimer\u2019s disease","volume":"25","author":"Robinson","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160517_ref148","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jalz.2008.12.001","article-title":"Alzheimer\u2019s disease and infection: Do infectious agents contribute to progression of Alzheimer\u2019s disease?","volume":"5","author":"Honjo","year":"2009","journal-title":"Alzheimer Dement"},{"key":"10.3233\/JAD-160517_ref149","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0046-8177(87)80252-6","article-title":"Concurrent neocortical borreliosis and Alzheimer \u2019s disease","volume":"18","author":"MacDonald","year":"1987","journal-title":"Hum Pathol"},{"key":"10.3233\/JAD-160517_ref150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00001756-199307000-00002","article-title":"Alzheimer\u2019s disease \u2013a spirochetosis?","volume":"4","author":"Miklossy","year":"1993","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-160517_ref151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004300050071","article-title":"Identification and localization of Chlamydia pneumoniae in the Alzheimer\u2019s brain","volume":"187","author":"Balin","year":"1998","journal-title":"Med Microbiol Immunol"},{"key":"10.3233\/JAD-160517_ref152","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains","volume":"33","author":"Jamieson","year":"1991","journal-title":"J Med Virol"},{"key":"10.3233\/JAD-160517_ref153","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711670403","article-title":"Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type","volume":"167","author":"Jamieson","year":"1992","journal-title":"J Pathol"},{"key":"10.3233\/JAD-160517_ref154","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-160517_ref155","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.142303","article-title":"Unconventional viruses and the origin and disappearance of Kuru","volume":"197","author":"Gajdusek","year":"1977","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref156","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0317167100044115","article-title":"Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved?","volume":"9","author":"Ball","year":"1982","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-160517_ref157","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphar.2014.00097","article-title":"HSV-1 and Alzheimer\u2019s disease: More than a hypothesis","volume":"5","author":"Piacentini","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-160517_ref158","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2449","article-title":"Herpes simplex virus type 1 DNA is located within Alzheimer\u2019s disease amyloid plaques","volume":"217","author":"Wozniak","year":"2009","journal-title":"J Pathol"},{"key":"10.3233\/JAD-160517_ref159","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.1127","article-title":"Herpesviruses in brain and Alzheimer\u2019s disease","volume":"197","author":"Lin","year":"2002","journal-title":"J Pathol"},{"key":"10.3233\/JAD-160517_ref160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/514600","article-title":"Herpes simplex viruses","volume":"26","author":"Whitley","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.3233\/JAD-160517_ref161","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11910-013-0414-8","article-title":"Update on herpes virus infections of the nervous system","volume":"13","author":"Steiner","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-160517_ref162","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(05)79057-7","article-title":"HSV-1 in brain and risk of Alzheimer disease","volume":"351","author":"Beffert","year":"1998","journal-title":"Lancet"},{"key":"10.3233\/JAD-160517_ref163","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s13365-011-0063-0","article-title":"Control of HSV-1 latency in human trigeminal ganglia-current overview","volume":"17","author":"Held","year":"2011","journal-title":"J Neurovirol"},{"key":"10.3233\/JAD-160517_ref164","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.plipres.2005.11.003","article-title":"Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer\u2019s disease and other disorders","volume":"45","author":"Itzhaki","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.3233\/JAD-160517_ref165","first-page":"1233","article-title":"Coexistence of Alzheimer disease neuropathology with herpes simplex encephalitis","volume":"49","author":"Denaro","year":"2003","journal-title":"Cell Mol Biol"},{"key":"10.3233\/JAD-160517_ref166","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/infdis\/jit210","article-title":"Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease","volume":"208","author":"Lurain","year":"2013","journal-title":"J Infect Dis"},{"key":"10.3233\/JAD-160517_ref167","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/infdis\/jiv052","article-title":"Reply to Itzhaki","volume":"211","author":"Barnes","year":"2015","journal-title":"J Infect Dis"},{"key":"10.3233\/JAD-160517_ref168","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/infdis\/jit665","article-title":"Cytomegalovirus: An improbable cause of Alzheimer disease","volume":"209","author":"Itzhaki1","year":"2014","journal-title":"J Infect Dis"},{"key":"10.3233\/JAD-160517_ref169","doi-asserted-by":"crossref","first-page":"e96779","DOI":"10.1371\/journal.pone.0096779","article-title":"Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer\u2019s disease","volume":"9","author":"Westman","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160517_ref170","doi-asserted-by":"crossref","first-page":"10259","DOI":"10.1021\/bi0508643","article-title":"Aggregation and porin-like channel activity of a \u03b2-sheet peptide","volume":"44","author":"Thundimadathil","year":"2005","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160517_ref171","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1073\/pnas.90.22.10573","article-title":"Giant multilevel cation channels formed by Alzheimer disease amyloid \u03b2-protein [A\u03b2P-(1-40)] in bilayer membranes","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160517_ref172","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrmicro.2015.3","article-title":"Pore-forming toxins: Ancient, but never really out of fashion","volume":"14","author":"Dal Peraro","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.3233\/JAD-160517_ref173","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by \u03b2-amyloid peptides in vitro: The role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160517_ref174","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer\u2019s disease-associated amyloid \u03b2-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160517_ref175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1432-1033.1996.0325z.x","article-title":"The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes","volume":"238","author":"Gudmundsson","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-160517_ref176","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamem.2015.11.003","article-title":"The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator","volume":"1858","author":"Xhindoli","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160517_ref177","doi-asserted-by":"crossref","first-page":"e101364","DOI":"10.1371\/journal.pone.0101364","article-title":"Alzheimer\u2019s associated \u03b2-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes","volume":"9","author":"White","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160517_ref178","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10522-014-9538-8","article-title":"\u03b2-Amyloid peptides display protective activity against the human Alzheimer\u2019s disease-associated herpes simplex virus-1","volume":"16","author":"Bourgade","year":"2015","journal-title":"Biogerontology"},{"key":"10.3233\/JAD-160517_ref179","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-150652","article-title":"Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture model","volume":"50","author":"Bourgade","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 4","key":"10.3233\/JAD-160517_ref180","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza virusaes","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.3233\/JAD-160517_ref181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1408.001","article-title":"Biology of influenza a virus","volume":"1102","author":"Cheung","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.3233\/JAD-160517_ref182","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","article-title":"Influenza: Old and new threats","volume":"10","author":"Palese","year":"2004","journal-title":"Nat Med"},{"key":"10.3233\/JAD-160517_ref183","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijid.2007.07.002","article-title":"Influenza viruses and the evolution of avian influenza virus, H5N1","volume":"12","author":"Skeik","year":"2008","journal-title":"Intern J Infect Dis"},{"key":"10.3233\/JAD-160517_ref184","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: Host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J Gen Virol"},{"key":"10.3233\/JAD-160517_ref185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-1-4614-7651-1_4","article-title":"Entry of influenza virus","volume":"790","author":"Sun","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JAD-160517_ref186","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1090284","article-title":"Three-dimensional structure of herpes simplex virus from cryo-electron tomography","volume":"302","author":"Gr\u00fcnewald","year":"2003","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref187","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/v4050800","article-title":"Herpes virus fusion and entry: A story with many characters","volume":"4","author":"Eisenberg","year":"2012","journal-title":"Viruses"},{"key":"10.3233\/JAD-160517_ref188","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/rmv.531","article-title":"Understanding HSV-1 entry glycoproteins","volume":"17","author":"Reske","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.3233\/JAD-160517_ref189","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","article-title":"Viral entry mechanisms: Cellular and viral mediators of herpes simplex virus entry","volume":"276","author":"Akhtar","year":"2009","journal-title":"FEBS J"},{"key":"10.3233\/JAD-160517_ref190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1126548","article-title":"Crystal structure of glycoprotein B from herpes simplex virus 1","volume":"313","author":"Heldwein","year":"2006","journal-title":"Science"},{"key":"10.3233\/JAD-160517_ref191","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/bi000029f","article-title":"Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer\u2019s A\u03b2 peptide","volume":"39","author":"Cribbs","year":"2000","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160517_ref192","doi-asserted-by":"crossref","first-page":"e00429-e00412","DOI":"10.1128\/mBio.00429-12","article-title":"The membrane-proximal region (MPR) of Herpes simplex virus gB regulates association of the fusion loops with lipid membranes","volume":"3","author":"Shelly","year":"2012","journal-title":"mBio"},{"key":"10.3233\/JAD-160517_ref193","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.3390\/v7122957","article-title":"Herpesvirus gB: A finely tuned fusion machine","volume":"7","author":"Cooper","year":"2015","journal-title":"Viruses"},{"key":"10.3233\/JAD-160517_ref194","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.str.2013.05.018","article-title":"The structure of Herpesvirus fusion glycoprotein B-bilayer complex reveals the protein-membrane and lateral protein-protein interaction","volume":"21","author":"Maurer","year":"2013","journal-title":"Structure"},{"key":"10.3233\/JAD-160517_ref195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrmicro2548","article-title":"Fusing structure and function: A structural view of the herpesvirus entry machinery","volume":"9","author":"Connolly","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.3233\/JAD-160517_ref196","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1099\/0022-1317-80-12-3189","article-title":"Mutations in the conserved carboxy-terminal hydrophobic region of glycoprotein gB affect infectivity of herpes simplex virus","volume":"80","author":"Wanas","year":"1999","journal-title":"J Gen Virol"},{"key":"10.3233\/JAD-160517_ref197","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1128\/JVI.00301-09","article-title":"Herpes Simplex virus glycoprotein B associates with target membranes via its fusion loops","volume":"83","author":"Hannah","year":"2009","journal-title":"J Virol"},{"key":"10.3233\/JAD-160517_ref198","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","article-title":"Molecular structure of \u03b2-amyloid fibrils in Alzheimer\u2019s disease brain tissue","volume":"154","author":"Lu","year":"2013","journal-title":"Cell"},{"key":"10.3233\/JAD-160517_ref199","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/156720508784533358","article-title":"Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer\u2019s disease and related disorders","volume":"5","author":"Rahimi","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-160517_ref200","first-page":"253","article-title":"Peptide model systems for amyloid fiber formation: Design strategies and validation methods","volume":"340","author":"Esteras-Chopo","year":"2006","journal-title":"Meth Mol Biol"},{"key":"10.3233\/JAD-160517_ref201","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1263\/jbb.99.437","article-title":"Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer\u2019s disease","volume":"99","author":"Irie","year":"2005","journal-title":"J Biosci Bioeng"},{"key":"10.3233\/JAD-160517_ref202","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1128\/JVI.77.17.9542-9552.2003","article-title":"Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry","volume":"77","author":"Bender Florent","year":"2003","journal-title":"J Virol"},{"key":"10.3233\/JAD-160517_ref203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-0934(02)00027-7","article-title":"Incorporation of green fluorescent protein into the essential envelope glycoprotein B of herpes simplex virus type 1","volume":"105","author":"Potel","year":"2002","journal-title":"J Virol Meth"},{"key":"10.3233\/JAD-160517_ref204","doi-asserted-by":"crossref","first-page":"340ra72","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-160517_ref205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2565","article-title":"Regulation of innate immune responses in the brain","volume":"9","author":"Rivest","year":"2009","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:01Z","timestamp":1777370641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":202,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160517","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}